Showing papers in "Journal of the American College of Cardiology in 2002"

TL;DR: The causes of variation are determined, there is no evidence for differences in incidence in different countries or times, and the incidences of individual major forms of CHD were determined from 44 studies.

TL;DR: State-of-the-art information is presented and insights are provided into the strengths and limitations of high-resolution ultrasonography of the brachial artery to evaluate vasomotor function, with guidelines for its research application in the study of endothelial physiology.

TL;DR: These guidelines represent an update of those published in 1996 and are intended for physicians who are involved in the preoperative, operative, and postoperative care of patients undergoing noncardiac surgery.

TL;DR: The current update of the ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices includes several significant changes in the recommendations and in the supporting narrative portion.

TL;DR: It is suggested that lung transplantation should be considered in a subset of patients who remain in NYHA functional class III or IV or in those who cannot achieve a significant hemodynamic improvement after three months of epoprostenol therapy, or both.

TL;DR: A strong association between myocardial viability on noninvasive testing and improved survival after revascularization in patients with chronic CAD and LV dysfunction is demonstrated.

TL;DR: Investigation of the effects of age and gender on plasma brain natriuretic peptide concentration in a population-based study confirmed that discriminatory values for BNP for detection of reduced ejection fraction were higher in women and older persons and were different between the two assays.

TL;DR: Coronary artery calcification is common, severe and significantly associated with ischemic cardiovascular disease in adult E SRD patients and the dysregulation of mineral metabolism in ESRD may influence vascular calcification risk.

TL;DR: Comparison between OCT and histology demonstrated that lipid-rich plaques and fibrous plaques have distinct OCT characteristics, and intracoronary OCT appears to be feasible and safe.

TL;DR: Cardiac resynchronization therapy produces a long-term improvement in the clinical symptoms of patients with HF who have a ventricular conduction delay, and the differences between optimized biventricular and unIVentricular therapy appear to be small for short-term treatment.

TL;DR: The ACC/AHA guidelines for exercise testing that were published in 1997 have now been updated as mentioned in this paper and the full-text guidelines incorporating the updated material are available on the Internet (www.acc.org or www.americanheart.org).

TL;DR: The American College of Cardiology/American Heart Association/National Heart, Lung and Blood Institute (ACC/AHA/NHLBI) Clinical Advisory is intended to summarize for professionals the current understanding of statin use, focused on myopathy, and to provide updated recommendations for the appropriate use of statins, including cautions, contraindications, and safety monitoring for statin therapy as mentioned in this paper.

TL;DR: The clinical benefits of BiV pacing appeared to be significantly maintained over a 12-month follow-up period.

TL;DR: Transcatheter closure of secundum ASD using the ASO is a safe and effective alternative to surgical repair and the length of hospital stay was shorter for device closure than for surgical repair.

TL;DR: Pericardial effusion, right atrial enlargement and septal displacement are echocardiographic abnormalities that reflect the severity of right heart failure and predict adverse outcomes in patients with severe PPH.

TL;DR: In patients with advanced heart failure and LBBB, baseline SPWMD is a strong predictor of the occurrence of reverse remodeling after CRT, thus suggesting its usefulness in identifying patients likely to benefit from biventricular pacing.

TL;DR: In chronic HF, relatively mild degrees of anemia are associated with worsened symptoms, functional status and survival, and low Hb proved to be an independent predictor of mortality.

TL;DR: Renal insufficiency is a strong predictor of death and subsequent cardiac events in a dose-dependent fashion during and after a percutaneous coronary intervention (PCI).

TL;DR: A formal education and support intervention substantially reduced adverse clinical outcomes and costs for patients with HF.

TL;DR: Beraprost improves exercise capacity and symptoms in NYHA functional class II and III patients with PAH and, in particular, in those with primary pulmonary hypertension.

TL;DR: Rapid testing of BNP in the ED should help differentiate pulmonary from cardiac etiologies of dyspnea.

TL;DR: Cardiac resynchronization significantly improved LV function and reversed LV remodeling during long-term follow-up and can be identified by TDI before implantation of a biventricular pacemaker.

TL;DR: In patients with known CAD who undergo PCI, very lean patients (BMI <18.5) and those with BMI within the normal range are at the highest risk for in-hospital complications and cardiac death and for increased one-year mortality.

TL;DR: After a number of adjustments, diastolic function profile remained incremental to history of congestive heart failure and previous myocardial infarction for prediction of NVAF.

TL;DR: Myocardial scarring is common in asymptomatic or mildly symptomatic HCM patients who have not suffered sudden death, and correlates positively with regional hypertrophy and inversely with regional contraction.

TL;DR: In survivors of out-of-hospital cardiac arrest, hemodynamic instability requiring administration of vasoactive drugs is frequent and appears several hours after hospital admission, suggesting post-resuscitation myocardial dysfunction.

TL;DR: This study demonstrates that a significant improvement in endothelial function may be obtained after six months of antihypertensive therapy and clearly identifies patients who possibly have a more favorable prognosis.

TL;DR: Obesity and insulin Resistance are both powerful predictors of CHD risk, and insulin resistance at any given degree of obesity accentuates the risk of CHd and type 2 diabetes.

TL;DR: A more extensive CAD is independently associated with shorter survival, and patients with single-vessel disease and no history of MI or revascularization should be classified as nonischemic for prognostic purposes.